Insomnia costing US workforce $63.2 billion a year in lost productivity, study shows

September 1, 2011 in Health

Insomnia is costing the average U.S. worker 11.3 days, or $2,280 in lost productivity every year, according to a study in the September 1 issue of the journal Sleep. As a nation, the total cost is 252.7 days and $63.2 billion.

"We were shocked by the enormous impact insomnia has on the average person's life," said lead author Ronald C. Kessler, Ph.D. "It's an underappreciated problem. Americans are not missing work because of insomnia. They are still going to their jobs but accomplishing less because they're tired. In an information-based economy, it's difficult to find a condition that has a greater effect on ."

The results were computed from a national sampling of 7,428 employees, part of the larger American Insomnia Study, which was led by Kessler and funded by Sanofi-Aventis Groupe. Participants were asked about habits and , among other things. Previous estimates have relied on smaller consumer panels and on medical and pharmacy claims databases focused on treated insomnia patients, the study said.

The estimated prevalence of insomnia in the AIS sample was 23.2 percent among employees. Insomnia also was found to be significantly lower (14.3 percent) among workers age 65 and older, and higher among working women (27.1 percent) than working men (19.7 percent). Clinical experts independently evaluated a subsample of AIS respondents and confirmed the accuracy of those estimates.

Kessler said accurate estimates on the costs of insomnia in the workplace might justify the implementation of screening and treatment programs for employees. Because insomnia is not considered an illness – the kind that results in lost days at work – employers tend to ignore its consequences, he said.

"Now that we know how much insomnia costs the American workplace, the question for employers is whether the price of intervention is worthwhile," said Kessler, a psychiatric epidemiologist with the Department of Health Care Policy at Harvard Medical School. "Can U.S. employers afford not to address insomnia in workplace?"

Roughly speaking, the average cost of treating insomnia ranges from about $200 a year for a generic sleeping pill to up to $1,200 for behavioral therapy, according to study co-author James K. Walsh, Ph.D., executive director and senior scientist at the Sleep Medicine and Research Center at St. Luke's Hospital in Chesterfield, Mo.

The SLEEP study also found a lower than average insomnia prevalence among respondents with less than a high school education (19.9 percent) and among college graduates (21.5 percent). Those with a high school education (25.3 percent) or some college education (26.4 percent) showed higher rates of prevalent . The AIS survey was conducted in 2008 and 2009.

More information: "Insomnia and the performance of US workers: Results from the America Insomnia Survey," Sleep.

Provided by American Academy of Sleep Medicine search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Systematic screening of med adherence will ID barriers

(HealthDay)—Implementation of systematic monitoring for medication adherence will allow for identification of barriers to adherence and tailoring of interventions, according to a viewpoint piece published ...

Health created 1 hour ago | popularity not rated yet | comments 0

More doctors, hospitals using electronic records

(AP)—The Obama administration says more doctors and hospitals are embracing technology as adoption of computerized medical records reaches a "tipping point" in America.

Health created 2 hours ago | popularity not rated yet | comments 0

Hospitals profit when patients develop bloodstream infections

Johns Hopkins researchers report that hospitals may be reaping enormous income for patients whose hospital stays are complicated by preventable bloodstream infections contracted in their intensive care units.

Health created 3 hours ago | popularity not rated yet | comments 0

Alleviating hunger in the US, it's a SNAP, researcher says

A University of Illinois researcher says that the cornerstone of our efforts to alleviate food insecurity should be to encourage more people to participate in the Supplemental Nutrition Assistance Program (SNAP) "because ...

Health created 3 hours ago | popularity not rated yet | comments 0

Parent and teacher support protects teens from sleep problems and depression

A new study suggests that disturbed sleep in adolescents is associated with more symptoms of depression and greater uncertainly about future success. However, perceived support and acceptance from parents and teachers appears ...

Health created 5 hours ago | popularity not rated yet | comments 0


Fecal microbiota tx feasible for recurrent C. difficile in HIV

(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Intern ...

FDA panel backs experimental Merck insomnia drug

(AP)—A federal panel of medical experts says that an experimental insomnia drug from Merck & Co Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty ...

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Novel approach for influenza vaccination shows promise in early animal testing

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...